Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amphetamine exposure is elevated in Parkinson's disease.

Elisabeth R Garwood1, Wosen Bekele, Charles E McCulloch

  • 1Pennsylvania State University School of Medicine, USA.

Neurotoxicology
|April 20, 2006
PubMed
Summary

Prolonged amphetamine use was more common in patients with Parkinson's disease (PD) and other neurological conditions. This suggests a potential link between long-term amphetamine exposure and PD development that warrants further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intake of Folate, Vitamin B6, and Vitamin B12 Before and After Disease Diagnosis and the Risk of Death in Individuals with Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Intraputaminal Delivery of Adeno-Associated Virus Serotype 2-Glial Cell Line-Derived Neurotrophic Factor in Mild or Moderate Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials.

Journal of Parkinson's disease·2024
Same author

Persistent mucus plugs in proximal airways are consequential for airflow limitation in asthma.

JCI insight·2023
Same author

A Novel Air Trapping Segment Score Identifies Opposing Effects of Obesity and Eosinophilia on Air Trapping in Asthma.

American journal of respiratory and critical care medicine·2023
Same author

NEMO reshapes the α-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62.

Nature communications·2023

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epidemiology

Background:

  • Amphetamines have been used therapeutically and recreationally since the 1930s.
  • High doses are linked to dopaminergic neuron injury, but the effects of prolonged low-dose exposure on Parkinson's disease (PD) risk are unknown.

Purpose of the Study:

  • To investigate the association between prolonged amphetamine exposure and the development of neurological conditions, specifically Parkinson's disease (PD).

Main Methods:

  • A telephone survey assessed drug and chemical exposure in patients diagnosed with peripheral neuropathy (PN), amyotrophic lateral sclerosis (ALS), or PD between ages 40-64.
  • Amphetamine exposure was defined as use of amphetamine, methamphetamine, or dextroamphetamine.
  • Prolonged exposure required use >twice/week for ≥3 months or weekly for ≥1 year, occurring before diagnosis.

Related Experiment Videos

Main Results:

  • Prolonged amphetamine exposure was observed in 15% with PN, 13% with ALS, and 11% with PD.
  • Diseased patients showed higher prolonged amphetamine exposure than controls (adjusted OR=3.15, p=0.005).
  • The PD group alone demonstrated statistical significance (adjusted OR=8.04, p=0.013), with exposure occurring ~27 years before diagnosis.

Conclusions:

  • An elevated rate of prolonged amphetamine exposure was found in Parkinson's disease (PD) patients.
  • This intriguing association necessitates further investigation into the potential link between amphetamine use and PD.